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Abstract
Background: The base excision repair pathway is responsible for repairing small DNA base
lesions caused by endogenous and exogenous damaging agents. Repair is initiated by DNA
glycosylases that recognize and remove the lesions. NEIL3 is one of 11 mammalian DNA
glycosylases identified to date and it was discovered on the basis of sequence homology to the E.
coli Fpg and Nei glycosylases. Difficulties in purifying the protein have limited its biochemical
characterization and in contrast to the other glycosylases, its function remains unclear.
Results: In this study we describe the expression pattern of Neil3 during mouse embryonic
development with special focus on brain development. We have also looked at the expression of
NEIL3 in several normal and tumor tissues. Quantitative real-time PCR and in situ hybridization
revealed that Neil3 was highly expressed at embryonic days 12–13, when neurogenesis starts. The
expression decreased during development and in the adult brain,Neil3 could not be detected in any
of the brain areas examined by quantitative real-time PCR. During embryogenesis and in newborn
mice specific expression was observed in areas known to harbour neural stem and progenitor cells
such as the subventricular zone and the dentate gyrus. Finally, NEIL3 expression was higher in
tumors compared to normal tissues, except for testis and pancreas.
Conclusion: Our findings indicate that mammalian NEIL3 is specifically expressed in brain areas
where neurogenesis takes place during development and that its expression is tightly regulated
both temporally and spatially. In addition, NEIL3  seems to be upregulated in tumor tissues
compared to normal tissues. Altogether, mammalian NEIL3 seems to be highly expressed in cells
with high proliferative potential.
Background
The base excision repair (BER) pathway, one of the major
DNA repair pathways, is dedicated to the repair of dam-
aged DNA bases arising from endogenous and exogenous
insults [1-4]. The DNA bases may be subjected to oxida-
tion, alkylation and deamination and oxidative DNA
damage, in particular, has been implicated in the patho-
genesis of many diseases including cancer, atherosclero-
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sis, neurodegenerative diseases such as Parkinson's and
Alzheimer's, and even aging [5-8]. DNA glycosylases are
the key enzymes of BER; they initiate repair by catalysing
the hydrolysis of the N-glycosylic bond between modified
bases and the sugar-phosphate backbone [1,3,4,9]. To
date, four mammalian DNA glycosylases that recognize
and excise oxidized bases have been thoroughly character-
ized: OGG1, NTH1, NEIL1 and NEIL2 [10-12]. NEIL3 was
identified together with NEIL1 and NEIL2 as a gene prod-
uct with significant structural similarities to the E. coli Fpg
and Nei DNA glycosylases [13-15]. However, in contrast
to NEIL1 and NEIL2 no substantial DNA glycosylase activ-
ity has been detected [13,14,16,17]. Expression of human
NEIL3  has been reported in thymus and testis, while
mouse  Neil3  has been demonstrated to be highly
expressed in spleen, bone marrow, thymus, blood cells
and brain regions that harbour progenitor cells
[13,18,19].  NEIL3  has also been shown to be highly
expressed in primary malignant melanomas associated
with metastasis [20]. Most studies have been performed
on adult organs and a recent paper described Neil3 expres-
sion in the developing mouse [17]. Here, we describe the
expression pattern of Neil3  during embryonic develop-
ment in mice with focus on the expression of Neil3 during
brain development. The expression of NEIL3 in multiple
human cancers was also examined.
Results
Neil3 is expressed during embryogenesis
The temporal expression pattern of Neil3 during embry-
onic development was examined by in silico electronic
Northern blot (eNorthern) and Northern blot analysis.
We used the UniGene collection http://
www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=unigene to
generate in silico expression profiles for Neil3 at different
stages during embryonic development. As seen in Figure
1A, there is a very high expression in the oocyte, unferti-
lised oocyte and zygote and this expression dramatically
falls after the zygote stadium. During embryogenesis,
Neil3 transcription is not detected until E8.5–11.5. North-
ern blot analysis was performed by using a northern blot
containing poly(A)+  RNA isolated from whole mouse
embryos at days 7, 11, 15 and 17 of gestation. Expression
of Neil3 was not observed until E11 (Figure 1B).
Neil3 is highly expressed in developing brain
Next, we examined the expression of Neil3 in developing
mouse brain. Messenger RNA was isolated from brains at
days 9.5, 12.5 and 17.5 of gestation and at P0 (birth) and
subjected to quantitative real-time PCR. Figure 2A shows
the expression levels of Neil3 relative to Gapdh. The high-
est expression level of Neil3 was observed at E12.5. To dis-
sect the sites of Neil3  expression, we evaluated the
distribution of Neil3  by transcript profiling in various
brain regions at five different stages of development: E13,
E15 and E18 (embryo), P7 (neonatal) and 5 weeks
(adult). As seen in Figure 2B, Neil3 expression was highest
at E13 in the fore- and midbrain and the expression
decreased during development. In neonatal mice the
expression was relatively low in all areas examined, except
for in the cerebellum and the spinal cord. In adult mice,
Neil3 expression was below the detection limit (data not
shown).
Neil 3 is highly expressed in regions of active neurogenesis 
in the developing brain
In order to characterize in more detail the expression of
Neil3 mRNA in developing brain, in situ hybridization was
performed on foetal mouse forebrains at E12, E17.5 and
P0 (Figure 3). At E12 abundant Neil3 mRNA was detected
in the subventricular zone (SVZ) of the lateral ventricles
(LV). The expression of Neil3 decreased during develop-
ment and at E17.5 and P0, expression was limited to dis-
tinct cells in the cortical SVZ, in cells of the secondary
matrix (SM), the dentate gyrus migratory route (DGM)
and the dentate gyrus (DG). Thus, Neil3 was expressed in
regions that are rich in progenitor cells. No signals were
detected for the sense DIG-RNA probe used as a control
(data no shown).
NEIL3 is expressed in various tumor samples
NEIL3 has recently been shown to be highly expressed in
melanomas [20]. We therefore investigated the expression
of NEIL3 in several tumor types and their normal counter-
parts by using qPCR arrays containing cDNA from dis-
eased and normal tissues. Data shown in Figure 4 is from
one of the two experiments performed and represents rel-
ative NEIL3 mRNA levels in normal and tumor tissues.
Raw data and information about the samples examined
are shown in Additional file 1. Results revealed that
although we observed high variation within the different
cancer samples from the same tissue, tumor samples in
general displayed a higher expression of NEIL3 than the
corresponding normal tissues, except for testis and pan-
creas. Furthermore, NEIL3 was highly abundant in nor-
mal testis tissue, as has been described before [13].
Discussion
In this study the expression of Neil3 during embryonic
brain development was investigated. Our results showed
that Neil3 was not uniformly expressed in the brain, but
limited to specific cells in certain regions. The expression
appeared to be tightly regulated both spatially and tempo-
rally during brain development.
Results from Northern blot analysis of total embryos
revealed the presence of Neil3  after E7, while RT-PCR
experiments showed the presence of Neil3 in the develop-
ing brain from E9. Thus, the expression of Neil3 appears
to coincide with organogenesis. This is also supported by
the  in silico analysis, where Neil3  transcripts were not
detected until E8.5–E11.5. Intriguingly, the in silico analy-BMC Neuroscience 2009, 10:45 http://www.biomedcentral.com/1471-2202/10/45
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sis revealed high expression of Neil3 during preimplanta-
tion. Mammalian embryos undergo major changes in
their gene expression patterns throughout most stages of
preimplantation development and massive maternal deg-
radation of mRNA characterizes the transition from
oocyte to early embryo before the onset of new transcrip-
tion [21,22]. Genes that follow this expression pattern are
suggested to have specific functions either in oogenesis,
oocyte maturation, fertilization, and/or early phases of
preimplantation development [23-25]. Our results sug-
gest that Neil3 can be classified with this group of genes
since Neil3 mRNA is highly expressed in unfertilised eggs
and is abundant up to the zygote stadium before it is
apparently degraded.
In mice, embryonic neurogenesis occurs from E12 to E17
[26,27]. There are two major proliferative populations in
the developing brain [28]. The first to appear is a region
called the ventricular zone (VZ) in the lateral ventricle.
The VZ is lined by a population of cells that contains
Expression analysis of Neil3 during embryonic development Figure 1
Expression analysis of Neil3 during embryonic development. (A) Expression profiles of Neil3 based on the EST profile 
viewer at the NCBI homepage. TPM, transcripts per million. (B) A multiple tissue northern blot containing poly(A)+ RNA from 
mouse embryo tissues at four different developmental stages was hybridized with 32P-labeled cDNA probes for Neil3 and β-
actin.BMC Neuroscience 2009, 10:45 http://www.biomedcentral.com/1471-2202/10/45
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multipotent neural stem cells that give rise to most neu-
rons and glial cells of the cortex. These cortical precursor
cells constitute a heterogeneous population and there is
increasing evidence that different precursor cells generate
distinct differentiated cell types [29-33]. Another prolifer-
ative population is found in the subventricular zone
(SVZ), located adjacent to the VZ along the lateral ventri-
cle. Notably, neurogenesis continues in this region
throughout adulthood, and in the adult mammalian
brain, new neurons born in the SVZ migrate anteriorly
into the olfactory bulb (OB), where they mature [34-36].
In post-natal mice, a second germinal zone exists; the sub-
granular zone (SGZ) of dentate gyrus in the hippocampus
[36,37]. Our in situ results showed that during brain
development Neil3 was highly expressed in cells found in
places rich in neural progenitors such as the VZ and the
SVZ. The expression decreased during embryonic develop-
ment and at P0, only a few cells around the lateral ventri-
cles and in the dentate gyrus of the hippocampus were
positive for Neil3 expression. We have recently described
the distribution of Neil3 during postnatal development
and found Neil3 expression in the SVZ, the rostral migra-
tory stream (RMS), the dentate gyrus of the hippocampal
formation and the Purkinje cells of the cerebellum in P3
Expression analysis of Neil3 in embryonic brain development Figure 2
Expression analysis of Neil3 in embryonic brain development. (A) Real-time quantitative PCR was performed on 
mRNA isolated from mouse brains at four different developmental stages. The data were normalized to Gapdh and expressed 
relative to the level of Neil3 at P0. (B) A detailed expression profile of Neil3 during brain development was obtained by using a 
mouse developmental tissue qPCR array. The array contains one concentration of cDNAs, normalized to Gapdh. Neil3 mRNA 
levels were calculated relative to the sample expressing the lowest level of Neil3 (Fron Cx, P7). The experiment was conducted 
twice and the standard deviations are indicated. Abbreviations: Tel, telencephalon; Die, diencephalon; Mes, mesencephalon 
(midbrain); Rhom, Rhombencephalon; Sp C, spinal cord; Mid B, midbrain; Med, medulla; Fron Cx, frontal cortex; Post Cx, pos-
terior cortex; Ent Cx, entorhinal cortex; Olf B, olfactory bulb; Hipp, hippocampus; Str, Striatum; Tha, thalamus; Hyp, hypotha-
lamus; Cer, cerebellum.BMC Neuroscience 2009, 10:45 http://www.biomedcentral.com/1471-2202/10/45
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mice. The expression of Neil3 decreased dramatically in
postnatal mice so that in 1-month-old mice only a few
cells in the SVZ and in layer V of neocortex were detected.
In 1-year-old mice Neil3 was detected in layer V of neocor-
tex only [19]. In the present study no Neil3 expression was
d e t e c t e d  i n  b r a i n s  f r o m  5 - w e e k - o l d  m i c e  w h e n  u s i n g
quantitative real-time PCR. The discrepancy between our
results and the previously reported data could be due to a
lower sensitivity of real-time PCR compared to in situ
hybridization. Thus, the limited number of Neil3-positive
cells detected in 1-month-old mice by in situ hybridiza-
tion is probably below the detection limit of the real-time
PCR. Altogether, previous data and results presented here
suggest that Neil3 is highly expressed in regions where
neurogenesis occurs during embryogenesis and to a lesser
extent in neonatal animals [19]. Hippocampal Neil3
expression disappeared in 1-month-old mice but could
still be observed in the SVZ [19]. This may suggest the
existence of different progenitors in the two germinal
areas. Since Neil3 appears to be enhanced in proliferating
cells, the decline in Neil3 expression during development
could be due to a decline in cell proliferation.
Neil3 knockout mice were generated a few years ago and
these mice are viable and remain apparently healthy into
adulthood with no overt phenotype [18]. A putative role
Expression of Neil3 in developing mouse forebrain Figure 3
Expression of Neil3 in developing mouse forebrain. In situ hybridisation was performed on coronal sections of mouse 
brains at different embryonic stages. Magnifications of Neil3-positive cells are shown to the right. Abbreviations: CA, hippocam-
pal differentiation fields; Ctx, cortex; DG, dentate gyrus; Hy, hypothalamus; LV, lateral ventricle; SM, secondary matrix; SVZ, 
subventricle zone.BMC Neuroscience 2009, 10:45 http://www.biomedcentral.com/1471-2202/10/45
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in lymphocytes and/or other immune cells has been pro-
posed since Neil3 is highly expressed in lymphatic cells
and tissues and the knockout mice have a slightly reduced
number of blood cells [18]. The expression pattern
described in this paper warrants a closer examination of
the distribution/phenotype of neural progenitor cells in
the embryo and adult Neil3 knockout mice. Studies using
the Neil3 knockout mice model that involve insults to the
brain such as ischemic stroke would be central in reveal-
ing whether Neil3 has a role in the regeneration of dam-
aged tissue.
In a recent study, NEIL3 was shown to be overexpressed in
primary melanomas giving rise to metastasis [20]. NEIL3
was therefore suggested to be associated with the progres-
sion of primary melanoma to distant metastasis [20].
Interestingly, we found increased NEIL3 expression in 16
of 18 cancer tissues compared to normal tissues. Intrigu-
ingly, NEIL3 has also recently been suggested to be a host
factor for HIV and thus, a target for antiviral medicines
[38]. Taken together all these observations and the fact
that no robust DNA glycosylase activity has been detected
[16,17], indicate that NEIL3 is not a typical DNA glycosy-
lase but rather a protein involved in processes where
extensive proliferation is a hallmark such as brain devel-
opment and possibly tumor development/progression.
Conclusion
We have characterized the expression pattern of Neil 3
during embryonic development. Our results clearly
showed that the expression of Neil3 appeared to be tightly
regulated both temporally and spatially. High expression
was detected in the oocytes and preimplantation stages of
development and later during organogenesis. In the
embryonic brain, Neil3 was detected in sites rich in neural
stem/progenitor cells. Finally, tumor tissues were shown
to express higher amounts of NEIL3 compared to their
normal counterparts, except for testis and pancreas. These
results call for a closer examination of the brains of Neil3
knock-out mice not only during development and aging,
but also under detrimental conditions such as ischemic
stress.
Expression of NEIL3 in human cancers Figure 4
Expression of NEIL3 in human cancers. Transcript profiling was performed by using a disease tissue qPCR array. cDNA 
concentrations are normalized to β-actin. Neil3 mRNA levels are calculated relative to the sample expressing the lowest level 
of Neil3 (one of the stomach cancer samples). Tumor and normal tissue samples were grouped according to their origin and 
the average and standard deviations were calculated for each group. The experiment was conducted twice and the results from 
one of the experiments are shown. Abbreviations: Adr G, adrenal gland; Bre, breast; Cer, cervix; Col, colon; End, 
endometrium; Eso, esophagus, Kid, kidney; Liv, liver; Lun, lung; Lym N, lymph node; Ova, ovary; Pan, pancreas; Pro, prostate; 
Sto, stomach; Tes, testis; Thy G, thyroid gland; Uri B, urinary bladder; Ute, uterus.BMC Neuroscience 2009, 10:45 http://www.biomedcentral.com/1471-2202/10/45
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Methods
Northern Blot Analysis
A mouse embryo MTN blot purchased from Clontech
(catalog no. 7763-1) was probed for Neil3  expression.
Northern blot hybridization was carried out using
ExpressHyb solution (Clontech) and probes were labeled
using the Rediprime DNA labeling system (Amersham
Biosciences), both according to the manufacturer's proto-
col. The full-length murine cDNA was used as a probe.
Real-time Quantitative PCR
Messenger RNA was isolated from the brains of embryos
and newborn mice (mixed background: 50% 129Sv and
50% C57BL/6) using the Dynabeads mRNA DIRECT Kit
(Dynal). The RNA was treated with TurboDNase (Applied
Biosystems) and cDNA synthesized using the High-
Capacity cDNA Reverse Transcription kit (Applied Bio-
sytems). The expression of glyceraldehyde-3-phosphate
dehydrogenase (Gapdh) mRNA was used as endogenous
control. Primers used: mouse Gapdh, forward 5'-TCG
TCC CGT AGA CAA AAT GGT-3'-, reverse 5'-CGC CCA
ATA CGG CCA AA-3'. Mouse Neil3, forward 5'-GGG CAA
CAT CAT CAA AAA TGA A-3', reverse 5'-CTG TTT GTC
TGA TAG TTG ACA CAC CTT-3'. Quantitative real-time
PCR was performed in 20-μl reactions containing 20 ng of
cDNA using the Power SYBR Green PCR master mix and
the Step One Plus real-time PCR system (both from
Applied Biosystems) according to the system and kit
instructions. Relative gene expression was calculated
using the comparative CT method and primers were
designed using the Primer Express software version 2.0
(Applied Biosystems).
To investigate more specifically the expression of Neil3 in
the developing mouse brain, a Mouse Developmental Tis-
sue qPCR array (MDRT101; OriGene Technologies) was
used. Neil3  primers used were the same as mentioned
above. The array contained normalized cDNA prepared
from various brain regions at five developmental stages.
The cDNAs were normalized against Gapdh. Relative gene
expression was calculated using the comparative CT
method. The data presented are relative Neil3 mRNA lev-
els.
For measurement of NEIL3 mRNA expression in normal
and tumor tissues, we used a Disease Tissue qPCR array
(CSRT303; OriGene Technologies). This array consisted
of normalized cDNA prepared from pathologist-verified
human tumor tissues obtained from 18 different tissues.
The cDNAs were normalized against β-actin. Clinical
information associated with each of these samples can be
found in Additional file 1. Primers used: Human NEIL3,
forward 5'-GGT CTC CAC CCA GCT GTT AAA G-3',
reverse 5'-CAC GTA TCA TTT TCA TGA GGT GAT G-3'.
Two parallel experiments were run and the raw data is pre-
sented in the additional file 1. Relative gene expression
was calculated using the comparative CT method. The
data presented are relative NEIL3 mRNA levels.
In situ hybridization
For characterization of Neil3 gene expression in the brain,
wild type (C57BL6/CBA F1 strain) embryos and newborn
mice were used. Coronal cryosections were prepared and
in situ hybridization was performed as previously
described [39]. A plasmid containing full-length mNeil3
(clone 4945750; Invitrogen,) was linearized with appro-
priate enzymes before sense and antisense riboprobes
were synthesized using a DIG RNA labeling kit (SP6/T7)
(catalog no. 1175025; Roche).
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